Baseline 18F-FDG Metabolic Tumor Volume Predicts Response to Rituximab Induction in Post-transplant Lymphoproliferative Disorders: A Multi-institutional Retrospective Study.
Morland D, Kanagaratnam L, Hubelé F, Toussaint E, Choquet S, Kas A, Caquot PA, Haioun C, Itti E, Leprêtre S, Decazes P, Bijou F, Schwartz P, Jacquet C, Chauchet A, Matuszak J, Kamar N, Payoux P, Durot E.
Morland D, et al. Among authors: itti e.
Hemasphere. 2023 Jan 24;7(2):e833. doi: 10.1097/HS9.0000000000000833. eCollection 2023 Feb.
Hemasphere. 2023.
PMID: 36713354
Free PMC article.